Glenmark gets USFDA nod for Fluphenazine Hydrochloride Tablets USP, 1 mg, 2.5 mg, 5 mg, 10 mg Read more
Lupin, Zydus sign licensing pact to co-market Saroglitazar Mg for chronic liver diseases in India Read more
Novel therapies to drive Crohn’s disease market growth across 8MM to $15 bn by 2032: GlobalData Read more
ImmunoACT to lead journey of indigenous CAR-T cell therapy in India but market access a hurdle: GlobalData Read more